GLP1R and type 2 diabetes mellitus: The human GLP-1 receptor agonists semaglutide, liraglutide, and dulaglutide successfully improved glycemic regulation in subjects with T2DM, and significantly reduced renal function, even in those on dialysis [86,87,88].